Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

EHA 2022 | The importance of genomics-based stratification in multiple myeloma

Monique Minnema • 11 Jun 2022
EHA 2022
Multiple Myeloma

Monique Minnema, MD, PhD, University Medical Center Utrecht, Utrecht, Netherlands, briefly discusses the importance of genomics-based stratification in multiple myeloma and how this is applied in the clinic. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Monique Minnema

Bing-Neel syndrome: a rare form of Waldenström’s macroglobulinemia
2:25
Bing-Neel syndrome: a rare form of Waldenström’s macroglobulinemia
Monique Minnema • 13 Nov 2024
Treating Bing-Neel syndrome: chemotherapy and BTK inhibitors
4:20
Treating Bing-Neel syndrome: chemotherapy and BTK inhibitors
Monique Minnema • 13 Nov 2024
Diagnosing Bing-Neel syndrome using MRI and lumbar puncture
1:27
Diagnosing Bing-Neel syndrome using MRI and lumbar puncture
Monique Minnema • 13 Nov 2024
Advice for physicians when managing bispecific antibody treatment for patients with myeloma
0:47
Advice for physicians when managing bispecific antibody treatment for patients with myeloma
Monique Minnema • 2 Jun 2024

Related Videos

Impact of Duffy status on PFS in newly diagnosed multiple myeloma treated with RVd ± autoSCT
4:13
Impact of Duffy status on PFS in newly diagnosed multiple myeloma treated with RVd ± autoSCT
Monique Minnema • 7 Dec 2025
Key multiple myeloma breakthroughs at ASH 2025
6:04
Key multiple myeloma breakthroughs at ASH 2025
Monique Minnema • 7 Dec 2025
A dual-targeting BCMA and CD19 FasTCAR-T (GC012F/AZD0120) as 1L therapy for newly diagnosed myeloma
4:18
A dual-targeting BCMA and CD19 FasTCAR-T (GC012F/AZD0120) as 1L therapy for newly diagnosed myeloma
Monique Minnema • 7 Dec 2025
Ultra-deep WGS of cell-free DNA to detect bone marrow-derived mutations in multiple myeloma
2:29
Ultra-deep WGS of cell-free DNA to detect bone marrow-derived mutations in multiple myeloma
Monique Minnema • 7 Dec 2025
The content of VJHemOnc is intended for healthcare professionals